Literature DB >> 23781581

Analysis of the risk factors for the recurrence of cervical cancer following ovarian transposition.

C Zhao1, J L Wang, S J Wang, L J Zhao, L H Wei.   

Abstract

PURPOSE: To investigate the potential risk factors related to the recurrence of cervical cancer following ovarian transposition.
MATERIALS AND METHODS: A total of 105 patients with cervical carcinoma were retrospectively analyzed. Each patient underwent surgical therapy in combination with ovarian transposition from September 2000 to November 2009. The potential risk factors for recurrence following ovarian transposition were analyzed.
RESULTS: The average age of the 105 patients was 38.7 years. Twelve patients were in Stage IA, 65 in IB, 12 in Stage IIA, and 16 in Stage IIB. Twenty-five patients had well-differentiated cancer (G1). Forty-eight patients had moderately-differentiated cancer (G2), and 32 patients had poorly-differentiated cancer (G3). Ninety-seven cases were squamous cell carcinoma, three were adenocarcinoma, four were small cell carcinoma, and one case was adenosquamous carcinoma. Five patients (4.8%) had a recurrence, two of whom (1.9%) had ovarian metastasis. Univariate analysis showed that the pathological type (p = 0.005) and degree of differentiation (p = 0.001) were potential risk factors for recurrence of cervical carcinoma following ovarian transposition. Cancer embolus in vessels or lymphatic metastasis was observed in four of the five patients who suffered a recurrence.
CONCLUSION: Pathological type, differentiated degree, and cancer embolus in vessels or lymphatic metastasis were identified as potential risk factors for the recurrence of cervical carcinoma after ovarian transposition.

Entities:  

Mesh:

Year:  2013        PMID: 23781581

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Diminished Utilization of in Vitro Fertilization Following Ovarian Transposition in Cervical Cancer Patients.

Authors:  Sana M Salih; Samet Albayrak; Songwon Seo; Sarah L Stewart; Kristen Bradley; David M Kushner
Journal:  J Reprod Med       Date:  2015 Jul-Aug       Impact factor: 0.142

2.  Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy?

Authors:  Itaru Soda; Hiromichi Ishiyama; Shigemitsu Ono; Kouji Takenaka; Masahide Arai; Tsutomu Arai; Haruko Iwase; Akane Sekiguchi; Shogo Kawakami; Shouko Komori; Takashi Onda; Kazushige Hayakawa
Journal:  J Radiat Res       Date:  2015-01-14       Impact factor: 2.724

Review 3.  Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation.

Authors:  Pirus Ghadjar; Volker Budach; Christhardt Köhler; Andreas Jantke; Simone Marnitz
Journal:  Radiat Oncol       Date:  2015-02-22       Impact factor: 3.481

4.  Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis.

Authors:  Alexandros Laios; Mohamed Otify; Argyro Papadopoulou; Ioannis D Gallos; Thomas Ind
Journal:  BMC Womens Health       Date:  2022-07-22       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.